Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA VaccineBusiness Wire • 07/07/21
South Korea Negotiating With mRNA COVID-19 Vaccine Makers To Produce Up To 1B Doses: ReutersBenzinga • 07/06/21
1 Great Reason to Buy Moderna (and It Has Nothing to Do With the COVID Vaccine)The Motley Fool • 07/06/21
Forensic Value Stock Selections: Top Positive And Negative Scoring Stocks For Mid-Year 2021Seeking Alpha • 07/06/21